Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2017 Filed Sep 19, 2017 19:27 UTC SaleCommon Stock 3,750 $91.26 $342,225.00
Disclosure

SEC source: 0001140361-17-035905 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,910

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:27 UTC Exercise / conversionCommon Stock 3,750 $38.59 $144,712.50
Disclosure

SEC source: 0001140361-17-035905 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:17 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 10,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-17-035899 · doc1.xml · derivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,934

Underlying: Common Stock · 10,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:17 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 5,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-17-035899 · doc1.xml · derivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,225

Underlying: Common Stock · 5,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:17 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 15,000 $90.50 $1,357,500.00
Disclosure

SEC source: 0001140361-17-035899 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,422

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $89.26 to $91.89. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:17 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 10,000 $37.46 $374,600.00
Disclosure

SEC source: 0001140361-17-035899 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:17 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 5,000 $26.49 $132,450.00
Disclosure

SEC source: 0001140361-17-035899 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
July 06, 2017 Filed Feb 15, 2018 01:16 UTC
FUCHS HENRY JPresident, Worldwide R&D
GiftCommon Stock 415 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-008543 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,561

F1 · date: On July 6, 2017, the reporting person gifted 415 shares to an educational institution.

Read SEC document
June 23, 2017 Filed Jun 28, 2017 00:46 UTC
Davis George EricEVP, General Counsel
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 9,844 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-17-026335 · doc1.xml · derivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 9,844 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
June 23, 2017 Filed Jun 28, 2017 00:46 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 9,844 $96.60 $950,930.40
Disclosure

SEC source: 0001140361-17-026335 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,581

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
June 23, 2017 Filed Jun 28, 2017 00:46 UTC
Davis George EricEVP, General Counsel
Exercise / conversionCommon Stock 9,844 $38.59 $379,879.96
Disclosure

SEC source: 0001140361-17-026335 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

Read SEC document
June 22, 2017 Filed Jun 23, 2017 21:39 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,671 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001140361-17-026024 · doc1.xml · derivative · entry 3

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,671 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 22, 2017 Filed Jun 23, 2017 21:39 UTC
Mueller BrianSVP, Corporate Controller
SaleCommon Stock 2,671 $100.00 $267,100.00
Disclosure

SEC source: 0001140361-17-026024 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
June 22, 2017 Filed Jun 23, 2017 21:39 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionCommon Stock 2,671 $21.51 $57,453.21
Disclosure

SEC source: 0001140361-17-026024 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.

Read SEC document
June 19, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 603 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · derivative · entry 9

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,331

Underlying: Common Stock · 603 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 19, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 603 $90.00 $54,270.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 6

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,422

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
June 19, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 603 $37.46 $22,588.38
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 9,397 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · derivative · entry 8

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,934

Underlying: Common Stock · 9,397 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 5,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · derivative · entry 7

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,225

Underlying: Common Stock · 5,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 9,397 $90.00 $845,730.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,422

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 5,000 $90.00 $450,000.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,819

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · price: All shares sold at the same price.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 9,397 $37.46 $352,011.62
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:33 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 5,000 $26.49 $132,450.00
Disclosure

SEC source: 0001140361-17-025625 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:31 UTC Exercise / conversionStock Option (right to buy) Common Stock · Derivative 3,750 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-17-025622 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 3,750 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:31 UTC SaleCommon Stock 3,750 $90.00 $337,500.00
Disclosure

SEC source: 0001140361-17-025622 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,910

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017

F2 · price: All shares sold at the same price.

Read SEC document
June 16, 2017 Filed Jun 20, 2017 22:31 UTC Exercise / conversionCommon Stock 3,750 $38.59 $144,712.50
Disclosure

SEC source: 0001140361-17-025622 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017

Read SEC document
June 09, 2017 Filed Jun 14, 2017 00:56 UTC
Davis George EricEVP, General Counsel
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,775 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-17-024913 · doc1.xml · derivative · entry 4

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,775 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 00:56 UTC
Davis George EricEVP, General Counsel
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,464 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001140361-17-024913 · doc1.xml · derivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,464 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 00:56 UTC
Davis George EricEVP, General Counsel
Exercise / conversionCommon Stock 3,775 $26.49 $99,999.75
Disclosure

SEC source: 0001140361-17-024913 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 00:56 UTC
Davis George EricEVP, General Counsel
Exercise / conversionCommon Stock 5,464 $21.51 $117,530.64
Disclosure

SEC source: 0001140361-17-024913 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 22:31 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 1,004 $89.61 $89,968.44
Disclosure

SEC source: 0001140361-17-024611 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,944

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F1 · deemedExecutionDate: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F2 · price: All shares sold at the same price.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:21 UTC GrantStock Option (Right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024502 · doc1.xml · derivative · entry 2

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:21 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024502 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,310

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:29 UTC GrantStock Option (right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024510 · doc1.xml · derivative · entry 2

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:29 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024510 · doc1.xml · nonDerivative · entry 1

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,885

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:31 UTC GrantStock Option (right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024512 · doc1.xml · derivative · entry 2

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:31 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024512 · doc1.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:32 UTC GrantStock Option (Right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024514 · doc1.xml · derivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:32 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024514 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,910

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:25 UTC GrantStock Option (right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024506 · doc1.xml · derivative · entry 2

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:25 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024506 · doc1.xml · nonDerivative · entry 1

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,810

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:27 UTC
LEWIS ALANDirector
GrantStock Option (right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024508 · doc1.xml · derivative · entry 2

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:27 UTC
LEWIS ALANDirector
GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024508 · doc1.xml · nonDerivative · entry 1

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,060

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:23 UTC GrantStock Option (right to buy) Common Stock · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024504 · doc1.xml · derivative · entry 2

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:23 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024504 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,185

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:18 UTC GrantStock Option (right to buy Common Stock) · Derivative 4,910 $0.00 Strike: $89.60 $0.00
Disclosure

SEC source: 0001140361-17-024500 · doc1.xml · derivative · entry 2

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

Underlying: Common Stock · 4,910 shares

Expires 2027-06-05

F2 · derivative.exercise_date: Option grant vests in full on June 6, 2018

Read SEC document
June 06, 2017 Filed Jun 8, 2017 22:18 UTC GrantCommon Stock 2,050 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-024500 · doc1.xml · nonDerivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,690

F1 · price: Restricted stock units granted on June 6, 2017. Price not applicable.

Read SEC document
June 05, 2017 Filed Jun 7, 2017 00:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-024234 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
June 05, 2017 Filed Jun 7, 2017 00:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $90.56 $452,800.00
Disclosure

SEC source: 0001140361-17-024234 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,924

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares sold at the same price.

Read SEC document
June 05, 2017 Filed Jun 7, 2017 00:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-024234 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.